rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathy L. Hibbs

Director

Company insider

Files Form 4 as: Director, SOPHiA GENETICS SA; Director, Standard BioTools; Chief Administrative Officer, 23andMe Holding Co; Director, SomaLogic; SVP & General Counsel, Genomic Health; Sr. VP, General Counsel, Monogram Biosciences.

In numbers

Trades disclosed
135
Buys
0
Sells
32
Bought
$0
Sold
$1.4M
Companies
6
Companies where not an officer
3
First trade
7 Apr 2006
Last trade
8 Sep 2026
Last filed
10 Sep 2026

Companies traded

Where they are an officer
23andMe Holding CoOfficer · last 20 May 20240 buys · 24 sells
Genomic HealthOfficer · last 18 Feb 20140 buys · 5 sells
Monogram BiosciencesOfficer · last 16 Jan 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SOPH SOPHiA GENETICS SADirector · Payments & Processors · last 8 Sep 20260 buys · 3 sells
LAB Standard BioToolsDirector · Life-science tools · last 18 Jun 20260 buys · 0 sells
SomaLogicDirector · last 5 Jan 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Sep 2026filed 10 Sep 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$51K6,250 at $8.13filing
8 Sep 2026filed 10 Sep 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$51K6,250 at $8.13filing
25 Aug 2026filed 26 Aug 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$54K6,250 at $8.68filing
25 Aug 2026filed 26 Aug 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$54K6,250 at $8.68filing
18 Jun 2026filed 23 Jun 2026LAB Standard BioToolsLife-science toolsSEC FORM 4 Code A—99,116 at $0.00filing
18 Jun 2026filed 23 Jun 2026LAB Standard BioToolsoption or derivative · Life-science toolsSEC FORM 4 Code A—175,923 at $0.00filing
18 Jun 2026filed 23 Jun 2026LAB Standard BioToolsoption or derivative · Life-science toolsSEC FORM 4 Code A—175,923 at $0.00filing
18 Jun 2026filed 23 Jun 2026LAB Standard BioToolsLife-science toolsSEC FORM 4 Code A—99,116 at $0.00filing
18 Jun 2026filed 22 Jun 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Code A$108K19,724 at $5.46filing
18 Jun 2026filed 22 Jun 2026SOPH SOPHiA GENETICS SAoption or derivative · Payments & ProcessorsSEC FORM 4 Code A$157K28,818 at $5.46filing
18 Jun 2026filed 22 Jun 2026SOPH SOPHiA GENETICS SAoption or derivative · Payments & ProcessorsSEC FORM 4 Code A$157K28,818 at $5.46filing
18 Jun 2026filed 22 Jun 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Code A$108K19,724 at $5.46filing
12 May 2026filed 13 May 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$35K7,508 at $4.67filing
12 May 2026filed 13 May 2026SOPH SOPHiA GENETICS SAPayments & ProcessorsSEC FORM 4 Sold$35K7,508 at $4.67filing
20 Jun 2025filed 24 Jun 2025LAB Standard BioToolsoption or derivative · Life-science toolsSEC FORM 4 Code A—125,660 at $0.00filing
20 Jun 2025filed 24 Jun 2025LAB Standard BioToolsLife-science toolsSEC FORM 4 Code A—94,592 at $0.00filing
28 Jun 2024filed 2 Jul 2024LAB Standard BioToolsoption or derivative · Life-science toolsSEC FORM 4 Code A—72,213 at $0.00filing
28 Jun 2024filed 2 Jul 2024LAB Standard BioToolsLife-science toolsSEC FORM 4 Code A—43,128 at $0.00filing
20 May 2024filed 21 May 202423andMe Holding CoSEC FORM 4 Code F$19K35,282 at $0.55filing
2 May 2024filed 6 May 202423andMe Holding Cooption or derivativeSEC FORM 4 Code M—38,551 at $0.00filing

News

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 5,000 Shares of Company StockSOPH · dailypolitical.com · 14 Oct 2026

0 headlines in the last 90 days name Kathy L. Hibbs; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Financials3
Not placed29

Buys in green, sells in red, by the company’s sector.

Related people

Zhenyu XuChief Scientific Officer · Also traded SOPH in the last 90 days
Jurgi CamblongExecutive Chairman · Also traded SOPH in the last 90 days
Philippe MenuChief Medical Officer · Also traded SOPH in the last 90 days
Abhimanyu VermaChief Technology Officer · Also traded SOPH in the last 90 days
Daan Van WellChief Legal Officer · Also traded SOPH in the last 90 days
George CardozaChief Financial Officer · Also traded SOPH in the last 90 days
Kevin PuylaertChief Sales Officer · Also traded SOPH in the last 90 days
Manuela ValenteChief People Officer · Also traded SOPH in the last 90 days